Ubs Asset Management Americas Inc Cogent Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 148,280 shares of COGT stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,280
Previous 135,604
9.35%
Holding current value
$1.79 Million
Previous $1.06 Million
15.99%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding COGT
# of Institutions
194Shares Held
115MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$110 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$108 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$107 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$88 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$84.1 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $794M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...